Controversy Surrounding New Zealand's E-Cigarette Quit Smoking Program

Jan.02

New Zealand Health Ministry to provide e-cigarette starter kits to aid adult smoking cessation, drawing criticism from health advocates.

According to NZ Herald on January 2nd, Casey Costello, the Deputy Minister of Health in New Zealand, announced that starting next week, e-cigarette starter kits will be provided to smoking cessation services nationwide to assist adults in quitting smoking. However, this move has been criticized by health advocates.

Letitia Harding, CEO of the Asthma and Respiratory Foundation, expressed concerns about the controversial practice of using e-cigarettes to quit smoking.

These products have not yet been approved for smoking cessation by the World Health Organization, the FDA (U.S. Food and Drug Administration), or the New Zealand Medicines and Medical Devices Safety Authority (Medsafe). Therefore, distributing these medications as therapeutic products without going through proper rigorous consultation procedures is truly bizarre. They are set to launch this plan next week, which seems too insane.

Harding noted that the plan lacks details and simply involves moving people from one product to another without a clear exit strategy.

Which products will actually receive funding, and how will they actually break free from long-term nicotine dependence on e-cigarette products? In the next decade or few decades, we may see a "New Zealand without e-cigarettes.

References:

[1] Smokefree advocates question Government's vaping plan

Also Read:

[1] New Zealand Government to Provide Free E-cigarette Starter Packs

[2] New Zealand Strengthens Regulation on E-Cigarettes: Disposable Ban Effective from June, 2025

[3] New Zealand Government Passes Strict Anti-Smoking Regulations

#Legislation #Open system e-cigarettes #Market #Australia #Oceania #New Zealand

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Vape Company Takes FDA to Court for Stalling Premarket Decision for Half a Decade

California-based vape manufacturer Schwartz E-Liquid (USA Vape Lab) has sued the U.S. Food and Drug Administration (FDA) in federal court, alleging the agency unlawfully failed to issue a decision on its premarket application for flavored e-cigarette products for more than five years. The company is seeking a court order compelling the FDA to act within 90 days.

Nov.26 by 2FIRSTS.ai

Product | INNOKIN Launches Magnetic Open-System Device, Pod + Power Bank Design Debuts in UK and US Channels

INNOKIN has recently launched its new open-system e-cigarette, EZ LEVA, on its official website, and it is now available through online channels in the UK and the United States. Featuring a magnetic design, the device adopts a pod + power bank form factor. Its 400mAh (device) + 2000mAh (charging case) battery setup follows a similar configuration logic to comparable products such as the SMOK Airmate and KIWI 2.

Dec.09 by 2FIRSTS.ai

Russian Lawmaker Sounds Alarm as Teenage Vaping Surges—Female Use Overtakes Male

Russia’s Chair of the State Duma Committee on Youth Policy warns that among 11–14-year-olds, girls now vape at higher rates than boys, a trend he calls “deeply concerning.” He says the spread of nicotine products—especially e-cigarettes—among minors poses a public health risk and warrants continued policy-level interventions.

Oct.17 by 2FIRSTS.ai

Expert Warns in 2Firsts Op-ed: Proposed COP11 Ban on Nicotine Pouches Would Be a Global Public Health Mistake

As global delegates prepare for COP11, a leaked EU position paper has sparked fresh debate over the future of nicotine pouch regulation. In an exclusive op-ed submitted to 2Firsts, Dr. Nveed Chaudhary, Chair of GINN’s Scientific Committee, argues that banning nicotine pouches would be a profound public health mistake—one that ignores harm reduction science and risks reversing global progress in smoking cessation.